Table 2 Baseline characteristics of the study participants
Routine care group (n = 80) | RAM group (n = 80) | P | |
|---|---|---|---|
Age (years) | 76.0 (71.3 ~ 84.8) | 79.0 (71.0 ~ 85.0) | 0.787 |
Body mass index (kg/m2) | 21.7 (20.6 ~ 23.7) | 22.2 (20.3 ~ 23.7) | 0.537 |
ASA | 3 (2 ~ 4) | 3 (2 ~ 4) | 0.139 |
Preoperative comorbidity | |||
Diabetes mellitus | 10 | 8 | 0.803 |
Oral intake of antiplatelet | 11 | 14 | 0.664 |
Preoperative urinary tract infection | 9 | 11 | 0.812 |
Preoperative urethral catheter | 16 | 13 | 0.682 |
Pre-operative IPSS | 19.36 ± 6.38 | 18.63 ± 7.74 | 0.512 |
Prostate volume (ml) | 51.74 ± 15.28 | 50.76 ± 15.55 | 0.690 |
Total operative time (min) | 75.5 (52.3 ~ 97.0) | 75.0 (54.0 ~ 99.8) | 0.742 |
Pre-operative Q max (ml/s) | 8.15 (6.23 ~ 9.75) | 8.30 (6.80 ~ 9.60) | 0.783 |
Removal of urethral catheter (days) | 5 (4 ~ 6) | 5 (4 ~ 6) | 0.614 |
Hospital stays (days) | 4 (3 ~ 5) | 4 (3 ~ 5) | 0.621 |
Postoperative complications | |||
During stay in hospital | |||
Fever above 38 °C | 5 | 3 | 0.720 |
Clot retention requiring irrigation | 3 | 5 | 0.720 |
Clean intermittent catheterization/re-catheterization | 5 | 4 | 1.000 |
Pad use on discharge | 3 | 3 | 1.000 |
After discharge (within 3 months) | |||
Fever above 38 °C | 6 | 4 | 0.746 |
Pad usage | 3 | 1 | 0.620 |
Readmission during 3 months | 2 | 0 | 0.497 |